A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

  1. Fenaux, P.
  2. Giagounidis, A.
  3. Selleslag, D.
  4. Beyne-Rauzy, O.
  5. Mufti, G.
  6. Mittelman, M.
  7. Muus, P.
  8. Te Boekhorst, P.
  9. Sanz, G.
  10. Del Cañizo, C.
  11. Guerci-Bresler, A.
  12. Nilsson, L.
  13. Platzbecker, U.
  14. Lübbert, M.
  15. Quesnel, B.
  16. Cazzola, M.
  17. Ganser, A.
  18. Bowen, D.
  19. Schlegelberger, B.
  20. Aul, C.
  21. Knight, R.
  22. Francis, J.
  23. Fu, T.
  24. Hellström-Lindberg, E.
Journal:
Blood

ISSN: 1528-0020 0006-4971

Year of publication: 2011

Volume: 118

Issue: 14

Pages: 3765-3776

Type: Article

DOI: 10.1182/BLOOD-2011-01-330126 GOOGLE SCHOLAR

Sustainable development goals